Cognito Therapeutics Ltd. — Form D/A
Cognito Therapeutics Ltd. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2023-11-15. The offering totals $126.2M, of which $108.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-11-15
- Form: D/A
- Accession: 0001936187-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $126.2M
- Amount sold: $108.8M
- Remaining: $17.4M
- Investors: 13
- Date of first sale: 2022-06-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-450926
Issuer
- Name: Cognito Therapeutics Ltd.
- CIK: 0001936187
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Address: 1218 MASSACHUSETTS AVE, CAMBRIDGE, MA, 02138
- Phone: 8572015088
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Stephen Bruso | Director | New Haven, CT |
| Richard Kuntz | Director | Boston, MA |
| Laura Brege | Director | Foster City, CA |
| Gerald Chan | Director | Monaco, O9 |
| Helen Liang | Director | Cambridge, MA |
| Brent Vaughan | Director | Cambridge, MA |
| Brent Vaughan | Executive Officer | Cambridge, MA |
| Jeffrey Halis | Director | Cambridge, MA |
| Stephen Ghiglieri | Executive Officer | Cambridge, MA |
| Zach Malchano | Executive Officer | Cambridge, MA |
Other filings by this issuer (2)
More